SVB FINANCIAL GROUP - Q3 2023 holdings

$53.2 Million is the total value of SVB FINANCIAL GROUP's 21 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 12.5% .

 Value Shares↓ Weighting
COIN  COINBASE GLOBAL INC$30,555,533
+4.9%
406,9730.0%57.48%
+4.4%
 ROOT INCcl a$7,446,444
+6.4%
783,0120.0%14.01%
+5.9%
OKTA SellOKTA INCcl a$6,451,680
-6.9%
79,152
-20.7%
12.14%
-7.3%
AXSM  AXSOME THERAPEUTICS INC$2,365,707
-2.7%
33,8490.0%4.45%
-3.2%
 STRUCTURE THERAPEUTICS INCsponsored ads$1,782,498
+21.3%
35,3530.0%3.35%
+20.7%
 ORCHESTRA BIOMED HOLDINGS INC$1,108,033
+24.6%
127,0680.0%2.08%
+24.0%
 MOONLAKE IMMUNOTHE RAPEUTICSclas s a ord$921,861
+11.8%
16,1730.0%1.73%
+11.2%
 ROVER GROUP INC$660,643
+27.5%
105,5340.0%1.24%
+27.0%
CMAX  CAREMAX INC$636,000
-31.8%
300,0000.0%1.20%
-32.2%
 PLANET LABS PBC$447,452
-19.3%
172,0970.0%0.84%
-19.6%
GLBE  GLOBAL E ONLINE LTD$203,230
-2.9%
5,1140.0%0.38%
-3.5%
CGEM  CULLINAN ONCOLOGY INC$122,320
-15.9%
13,5160.0%0.23%
-16.4%
 CARIBOU BIOSCIENCES INC$99,013
+12.5%
20,7140.0%0.19%
+12.0%
GBIO SellGENERATION BIO CO$94,879
-38.1%
25,034
-10.2%
0.18%
-38.6%
PACB  PACIFIC BIOSCIENCES CALIF IN$85,579
-37.2%
10,2490.0%0.16%
-37.6%
SKLZ BuySKILLZ INC$71,145
-42.9%
13,950
+1.9%
0.13%
-43.2%
ALVR SellALLOVIR INC$36,995
-57.8%
17,207
-33.3%
0.07%
-57.8%
 MOVELLA HOLDINGS INC$29,780
-74.8%
55,5280.0%0.06%
-75.0%
VERO  VENUS CONCEPT INC$20,907
-8.0%
10,6670.0%0.04%
-9.3%
ELDN SellELEDON PHARMACEU TICALS INC$18,457
-25.3%
13,472
-25.3%
0.04%
-25.5%
 MOLEKULE GROUP INC$3,081
-93.8%
21,2470.0%0.01%
-93.6%
ExitGREENLIGHT BIOSCIENCES HLDS P$0-16,950
-100.0%
-0.01%
ExitPARDES BIOSCIENCES INC$0-35,923
-100.0%
-0.12%
ExitDICE THERAPEUTICS INC$0-21,799
-100.0%
-1.91%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
COINBASE GLOBAL INC4Q3 202357.5%
OKTA INC4Q3 202320.9%
ROOT INC4Q3 202314.0%
AXSOME THERAPEUTICS INC4Q3 20237.1%
CAREMAX INC4Q3 20233.0%
PLANET LABS PBC4Q3 20232.0%
MOONLAKE IMMUNOTHERAPEUTICS4Q3 20231.7%
ROVER GROUP INC4Q3 20231.2%
CULLINAN ONCOLOGY INC4Q3 20230.8%
CARIBOU BIOSCIENCES INC4Q3 20230.8%

View SVB FINANCIAL GROUP's complete holdings history.

Latest significant ownerships (13-D/G)
SVB FINANCIAL GROUP Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
ACHIEVE LIFE SCIENCES, INC.February 10, 20231,716,7648.8%
Root, Inc.February 10, 2023783,0128.6%
BigCommerce Holdings, Inc.February 12, 2021392,2240.6%
ISC8 INC. /DEFebruary 17, 201534,533,21311.9%

View SVB FINANCIAL GROUP's complete significant-ownership history.

Latest filings
TypeFiled
8-K2024-03-22
8-K2024-03-20
8-K2024-02-26
13F-HR2024-02-14
SC 13G/A2024-02-14
8-K2024-02-09
8-K2024-02-01
8-K2024-01-29
SC 13G/A2024-01-17
8-K2024-01-10

View SVB FINANCIAL GROUP's complete filings history.

Compare quarters

Export SVB FINANCIAL GROUP's holdings